Franziska Böttger

My research interest lies in elucidating anti-cancer drug mechanisms and identifying predictive biomarkers through analysis of proteomics data.

I joined the group of Lodewyk Wessels in 2020 to work on a collaborative project with the OncoProteomics lab of Connie Jimenez (VUmc) aimed at identifying anti-EGFR therapy response prediction biomarkers and alternative drug targets in metastatic colorectal cancer.